“We have every reason to believe it will be effective,” said Dr. Robert A. Salata, chairman of the department of medicine at University Hospitals Cleveland Medical Center and principal investigator for the study.
The product, marketed commercially under the brand name Halo, has shown promise in preventing influenza and other respiratory illnesses in laboratory studies and in a small clinical trial that Salata supervised at University Hospitals in 2015-16.
